Acyclovir
Back to searchMolecule Structure
Scientific Name
Acyclovir
Description of the Drug
Acyclovir is a guanosine analog used to treat herpes simplex, varicella zoster, herpes zoster.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00787
http://www.drugbank.ca/drugs/DB00787
Brand Name(s)
Aciclovir, Acycloguanosine, Acyclovir, Avaclyr, Avert, Aviral, Clearsore, Cyclovir, Cymex ultra, Duvimex, Herpetad, Lipsore, Lypsyl, Ranovir, Sitavig, Soothelip, Soraway, Viralief, Virasorb, Virovir 200, Virovir 400, Virovir 800, Zovirax
Company Owner(s)
Cipla Ltd, Glaxosmithkline, Macleods Pharmaceuticals Ltd, Watson Laboratories Inc, Fougera Pharmaceuticals Inc, Actavis Mid Atlantic Llc, Taro Pharmaceuticals Usa Inc, Abbvie Inc, Mylan Pharmaceuticals Inc, Hospira Worldwide, Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human herpesvirus 1 DNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL1872 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3175 | ||||||
PharmGKB | PA448045 | ||||||
Human Metabolome Database | HMDB0014925 | ||||||
DrugBank | DB00787 | ||||||
PubChem: Thomson Pharma | 14773677 | 15172245 | 15220533 | ||||
PubChem | 135398513 | ||||||
Mcule | MCULE-2703274259 | ||||||
NMRShiftDB | 20025956 | ||||||
LINCS | LSM-5459 | ||||||
Nikkaji | J11.247J | ||||||
PDBe | AC2 | ||||||
BindingDB | 50103518 | 50021776 | |||||
EPA CompTox Dashboard | DTXSID1022556 | ||||||
DrugCentral | 85 | ||||||
Brenda | 173055 | 3062 | 153377 | 154360 | 17698 | 166474 | 4406 |
ChemicalBook | CB7126677 | ||||||
Guide to Pharmacology | 4829 | ||||||
rxnorm | LYPSYL | SITAVIG | ZOVIRAX | ACYCLOVIR SODIUM | ACYCLOVIR | ||
PubChem: Drugs of the Future | 12013356 | ||||||
KEGG Ligand | C06810 | ||||||
ChEBI | 2453 | ||||||
ZINC | ZINC000001530555 |